248 related articles for article (PubMed ID: 17119886)
1. [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].
Gretschel S; Bembenek A; Schulze T; Kemmner W; Schlag PM
Chirurg; 2006 Dec; 77(12):1104-17. PubMed ID: 17119886
[TBL] [Abstract][Full Text] [Related]
2. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R; Nekarda H; Thorban S; Siewert JR
Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
Wollenberg B; Walz A; Kolbow K; Pauli C; Chaubal S; Andratschke M
Onkologie; 2004 Aug; 27(4):358-62. PubMed ID: 15347890
[TBL] [Abstract][Full Text] [Related]
4. [Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies].
Siewert JR; Lordick F; Ott K; Brücher BL; Rosenberg R
Chirurg; 2006 Mar; 77(3):227-35. PubMed ID: 16511688
[TBL] [Abstract][Full Text] [Related]
5. [Development of minimal residual cancer cell research].
Iinuma H; Watanabe T
Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):177-84. PubMed ID: 22582577
[TBL] [Abstract][Full Text] [Related]
6. Detection and clinical significance of occult tumour cells in colorectal cancer.
Tsavellas G; Patel H; Allen-Mersh TG
Br J Surg; 2001 Oct; 88(10):1307-20. PubMed ID: 11578283
[TBL] [Abstract][Full Text] [Related]
7. [Reoperation for thyroid cancer].
Vogelsang H; Brückner T; Scheidhauer K; Schwaiger M; Siewert JR
Chirurg; 2005 Mar; 76(3):238-49. PubMed ID: 15739058
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
Partridge M; Li SR; Pateromichelakis S; Francis R; Phillips E; Huang XH; Tesfa-Selase F; Langdon JD
Clin Cancer Res; 2000 Jul; 6(7):2718-25. PubMed ID: 10914716
[TBL] [Abstract][Full Text] [Related]
9. Micrometastases: marker of metastatic potential or evidence of residual disease?
O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
[TBL] [Abstract][Full Text] [Related]
10. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
[TBL] [Abstract][Full Text] [Related]
11. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor.
Vogel I; Krüger U; Marxsen J; Soeth E; Kalthoff H; Henne-Bruns D; Kremer B; Juhl H
Clin Cancer Res; 1999 Mar; 5(3):593-9. PubMed ID: 10100711
[TBL] [Abstract][Full Text] [Related]
12. The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study.
Roberts A; Nofech-Mozes S; Youngson B; McCready DR; Al-Assi M; Ramkumar S; Cil T
Ann Surg Oncol; 2015 Oct; 22(10):3397-401. PubMed ID: 26215196
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
15. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.
Klein CA; Blankenstein TJ; Schmidt-Kittler O; Petronio M; Polzer B; Stoecklein NH; Riethmüller G
Lancet; 2002 Aug; 360(9334):683-9. PubMed ID: 12241875
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
[TBL] [Abstract][Full Text] [Related]
18. Detection of minimal disease in patients with solid tumors.
Pantel K
J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
20. [Oncologic surgery/pathologic-anatomic viewpoint].
Hermanek P
Langenbecks Arch Chir Suppl Kongressbd; 1991; ():277-81. PubMed ID: 1793916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
